Jinglei Qu
- Cancer Research top 10%
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 8
- Cancer-related Molecular Pathways 5
- Bone health and treatments 5
- Inflammatory Biomarkers in Disease Prognosis 5
-
- Gastric Cancer Management and Outcomes 12
- Metastasis and carcinoma case studies 5
-
- Hepatocellular Carcinoma Treatment and Prognosis 6
-
- Gastrointestinal Tumor Research and Treatment 5
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jinglei Qu
48 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 85
- Cancer Research 297
- Oncology 469
- Molecular Biology 611
- Immunology 183
- Pulmonary and Respiratory Medicine 213
Countries citing papers authored by Jinglei Qu
This map shows the geographic impact of Jinglei Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinglei Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinglei Qu more than expected).
Fields of papers citing papers by Jinglei Qu
This network shows the impact of papers produced by Jinglei Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinglei Qu. The network helps show where Jinglei Qu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jinglei Qu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 7 | |
| 3 | 2021 | 16 | |
| 4 | 2021 | 1 | |
| 5 | 2021 | 17 | |
| 6 | 2018 | 13 | |
| 7 | 2017 | 46 | |
| 8 | 2017 | 6 | |
| 9 | 2016 | 23 | |
| 10 | 2016 | 17 | |
| 11 | 2016 | 3 | |
| 12 | 2015 | 10 | |
| 13 | 2013 | 12 | |
| 14 | 2012 | 18 | |
| 15 | 2012 | 47 | |
| 16 | 2012 | 13 | |
| 17 | 2011 | 44 | |
| 18 | 2011 | 119 | |
| 19 | 2011 | 29 | |
| 20 | 2009 | 40 |
About Jinglei Qu
Jinglei Qu is a scholar working on Oncology, Gastroenterology and Hepatology, having authored 50 papers that have together received 1.1k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (12 papers), Colorectal Cancer Treatments and Studies (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Gastrointestinal Tumor Research and Treatment (5 papers), Cancer-related Molecular Pathways (5 papers), Bone health and treatments (5 papers), Metastasis and carcinoma case studies (5 papers) and Inflammatory Biomarkers in Disease Prognosis (5 papers). The work is most often cited by research in Cancer Research (297 citations), Oncology (469 citations) and Molecular Biology (611 citations). Jinglei Qu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiujuan Qu, Yunpeng Liu, Kezuo Hou, Ling Xu, Xiaofang Che, Yuee Teng, Ye Zhang, Zhi Li, Jingdong Zhang and Yibo Fan. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.